Findings of Sodium-Glucose Cotransporter-2 Inhibitor Kidney Outcome Trials Applied to a Canadian Chronic Kidney Disease Population: A Retrospective Cohort Study.
Tae Won YiMohammad AtiquzzamanYuyan ZhengBrendan SmythMeg JardineAdeera LevinPublished in: Canadian journal of kidney health and disease (2022)
The British Columbia cohort represents a high-risk group in whom implementation of the use of SGLT2 inhibitors may well improve outcomes and reduce health care system costs.